Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern

Acute myeloid leukemia (AML) is a heterogeneous malignancy affecting myeloid cells in the bone marrow (BM) but can spread giving rise to impaired hematopoiesis. AML incidence increases with age and is associated with poor prognostic outcomes. There has been a disconnect between the success of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Dozzo, Annachiara, Galvin, Aoife, Shin, Jae-Won, Scalia, Santo, O’Driscoll, Caitriona M., Ryan, Katie B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315355/
https://www.ncbi.nlm.nih.gov/pubmed/35930221
http://dx.doi.org/10.1007/s13346-022-01189-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315355/
https://www.ncbi.nlm.nih.gov/pubmed/35930221
http://dx.doi.org/10.1007/s13346-022-01189-4

Ejemplares similares